PERSPECTA

News from every angle

Back to headlines

AstraZeneca's Imfinzi Regimen Shows Success in Late-Stage Liver Cancer Trial

AstraZeneca announced positive results from a late-stage clinical trial for its Imfinzi regimen, demonstrating a win in the treatment of liver cancer.

2 Apr, 11:24 — 2 Apr, 11:24
PostShare

Sources

Showing 1 of 1 sources